L759-0152 Screening compound: 2-[4-(furan-2-carbonyl)piperazin-1-yl]-4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]quinoline

L759-0152 Screening compound: 2-[4-(furan-2-carbonyl)piperazin-1-yl]-4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]quinoline
L759-0152 Screening compound: 2-[4-(furan-2-carbonyl)piperazin-1-yl]-4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]quinoline alternative view

Chemical Structure Depiction of ChemDiv screening compound L759-0152
2-[4-(furan-2-carbonyl)piperazin-1-yl]-4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]quinoline

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L759-0152

Molecular Formula

C27H23N5O3 (C27 H23 N5 O3)

Compound Name

2-[4-(furan-2-carbonyl)piperazin-1-yl]-4-[3-(4-methylphenyl)-1,2,4-oxadiazol-5-yl]quinoline

IUPAC name

2-[4-(furan-2-carbonyl)piperazin-1-yl]-4-[3-(4-methylphenyl)-124-oxadiazol-5-yl]quinoline

SMILES

Cc(cc1)ccc1-c1noc(-c2cc(N(CC3)CCN3C(c3ccco3)=O)nc3ccccc23)n1

InChI

InChI=1S/C27H23N5O3/c1-18-8-10-19(11-9-18)25-29-26(35-30-25)21-17-24(28-22-6-3-2-5-20(21)22)31-12-14-32(15-13-31)27(33)23-7-4-16-34-23/h2-11,16-17H,12-15H2,1H3

InChI Key

FCFKFNSSGGGTHK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15134457

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

465.51

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.781

Distribution Coefficient, logD

5.781

Water Solubility, LogSw

-5.73

Polar Surface Area

67.925

Acid Dissociation Constant (pKa)

24.41

Base Dissociation Constant (pKb)

4.15

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

18.50

L759-0152 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Akt-Targeted Library (14764 compounds)

Anti-HIV1 Library (19540 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with L759-0152 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L759-0152?
Check Price and Availability of L759-0152, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L759-0152 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L759-0152
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L759-0152
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L759-0152 available by request